维普中文期刊产品整合服务
16篇 您的检索式:作者名="Yue MM"
    题名 作者 年代 出处 被引量
1Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention显示文摘Pascalle S Monraats Yue Fang Douwe Pons Nuno MM Pires Huibert AP Pols Aeilko H Zwinderman Moniek PM de Maat Pieter AF Doevendans Robbert J deWinter René A Tio Johannes Waltenberger Rune R Frants Paul HA Quax Arnoud van der Laarse Ernst E van der Wall Andr 2010Expert Opinion on Therapeutic Targets2010,,:1
2In pulmonary lymphangio- leiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor显示文摘Gao L Yue MM Davis J 2014Vir- chows Arch2014,464,4:1
3Quantitation of nicotine, its metabolites, and other related alkaloids in urine, serum, and plasma using LC-MS-MS 显示文摘Yue B Kushnir MM Urry FM 2010Methods Mol Biol2010,603,38:1
4Nonlinear multiscale wavelet diffusion for speckle suppression and edge enhancement in ultrasound images 显示文摘Yong Yue Croitoru MM Bidani A 2006IEEE Transactions on Medical Imaging2006,25,3:1
5Nonlinear multiscale wavelet diffusion for speckle suppression and edge enhancement in ultrasound images显示文摘Yue Yong Croitoru MM Bidani A 2006IEEE Trans Medical Imaging2006,25,3:1
6The p38 MAPK inhibitor, SB203580,abrogates ischaemic preconditioning in rat heart but timing of administration is critical显示文摘Mocanu MM Baxter GF Yue Y 2000Basic Res Cardiol2000,95,6:1
7De novo mutation in CACNA1A Cause dacetazolamide responsive episodic at axia显示文摘Yue Q Jen JC Thwe MM 1998Am J Med Genet1998,77,4:1
8The p38 MAPK inhibitor,SB203580,abrogates ischaemic preconditioning in rat heart but timing of administration is critical显示文摘Mocanu MM Baxter GF Yue Y 2000Basic Res Cardiol2000,95,6:1
9The p38 MAPK inhibitor, SB203580, abrogates ischemic preconditioning in rat heart but timing of administration is critical显示文摘Mocanu MM Baxter GF Yue Y 2000Basic Res Cardiol2000,95,6:1
10IFN induces miR-21 through a signal transformation and activator of transcrip- tion 3-dependent pathway as a suppressive negative feed- back on IFN induced apoptosis 显示文摘Yang CH Yue J Fan MM 2010Cancer Res2010,70,:1
11Clinical application of the Panjabi neutral zone hypothesis:the Stabilimax NZ posterior lumbar dynamic stabilization system显示文摘Yue JJ Timm JP Panjabi MM 2007Neurosurg Focus2007,22,1:1
12Clinical application of the Panjabi neutral zone hypothesis:the Stabilimax NZ posterior lumbar dynamic stabilization system显示文摘Yue JJ Timm JP Panjabi MM 0,,01:1
13De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia显示文摘 Jen JC Thwe MM 1998Am J Med Genet1998,77,4:1
14De novo mutation in CACNAIA causedacetazolamide-responsive episodic at axia显示文摘Yue Q Jen JC Thwe MM 1998Am J Med Genet1998,77,4:1
15Clinical application of the Panjabi neutral zone hypothesis :the Stabilimax NZ posterior lumbar dynamic stabilization system 显示文摘Yue JJ Timm JP Panjabi MM 2007Neurosurg Focus2007,22,1:1
16Calcium-Sensing Receptor of Immune Cells and Diseases显示文摘Calcium-sensing receptor(CaSR),which was initially found in the parathyroid gland,is ubiquitously expressed and exerts specifi c functions in multiple cells,including immune cells.CaSR is functionally expressed on neutrophils,monocytes/macrophages,and T lymphocytes,but not B lymphocytes,and regulates cell functions,such as cytokine secretion,chemotaxis,phenotype switching,and ligand delivery.In these immune cells,CaSR is involved in the development of many diseases,such as sepsis,cryopyrin-associated periodic syndromes,rheumatism,myocardial infarction,diabetes,and peripheral artery disease.Since its discovery,it has been controversial whether CaSR is expressed and plays a role in immune cells.This article reviews current knowledge of the role of CaSR in immune cells.Wenxiu Liu Yutong Guo MM Yue Liu Jiaxing Sun Xinhua Yin 2021Cardiovascular Innovations and Applications2021,,2:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费